The Editor's Roundtable: Implantable Cardioverter-Defibrillators in Primary Prevention of Sudden Cardiac Death and Disparity-Related Barriers to Implementation

  • Vincent E. Friedewald
    Corresponding author: Tel: 574-631-6675; fax: 574-631-4505
    Associate Editor, The American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Research Professor, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Gregg C. Fonarow
    The Eliot Corday Professor in Cardiovascular Medicine and Science, UCLA Division of Cardiology, University of California, Los Angeles, Los Angeles, California
    Search for articles by this author
  • Brian Olshansky
    Professor of Medicine, University of Iowa College of Medicine, Iowa City, Iowa
    Search for articles by this author
  • Clyde W. Yancy
    Medical Director, Baylor Heart and Vascular Institute of Baylor University Medical Center, and Chief, Cardiothoracic Transplantation, Baylor University Medical Center, Dallas, Texas
    Search for articles by this author
  • William C. Roberts
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute of Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
      This CME activity is supported by an educational grant from Medtronic, Inc. , Minneapolis, Minnesota.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mirowski M.
        • Reid P.R.
        • Mower M.M.
        • Watkins L.
        • Gott V.L.
        • Schauble J.F.
        • Langer A.
        • Heilman M.S.
        • Kolenik S.A.
        • Frischell R.D.
        • Weisfeldt M.L.
        Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings.
        N Engl J Med. 1980; 303: 322-324
        • Mirowski M.
        • Mower M.M.
        • Langer A.
        • Heilman M.S.
        • Schreibman L.
        A chronically implanted system for automatic defibrillation in active conscious dogs: experimental model for treatment of sudden death from ventricular fibrillation.
        Circulation. 1978; 58: 90-94
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • Estes N.A.M.
        • Freedman R.A.
        • Gettes L.S.
        • Gillinov A.M.
        • Gregoratos G.
        • Hammill S.C.
        • Hayes D.L.
        • Hlatky M.A.
        • Newby L.K.
        • Page R.L.
        • Schonfeld M.H.
        • Sitka M.J.
        • Stevenson L.W.
        • Sweeny M.O.
        ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary.
        Circulation. 2008; 117: 2820-2840
        • Hohnloser S.H.
        • Kuck K.H.
        • Dorian P.
        • Roberts R.S.
        • Hampton J.R.
        • Hatala R.
        • Fain E.
        • Gent M.
        • Connolly S.J.
        • DINAMIT Investigators
        Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
        N Engl J Med. 2004; 351: 2481-2488
        • Fonarow G.C.
        • Yancy C.W.
        • Albert N.M.
        • Curtis A.B.
        • Gattis Stough W.
        • Gheorghiade M.
        • Heywood J.T.
        • Mehra M.
        • O'Connor C.M.
        • Reynolds D.
        • Walsh N.M.
        Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
        Am Heart J. 2007; 154: 12-38
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • Poole J.E.
        • Packer D.L.
        • Boineau R.
        • Domanski M.
        • Troutman C.
        • Anderson J.
        • Johnson G.
        • McNulty S.E.
        • Clapp-Channing N.
        • Davidson L.D.
        • Fraulo E.S.
        • Fishbein D.P.
        • Luceri R.M.
        • Ip J.H.
        • Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Hernandez A.F.
        • Fonarow G.C.
        • Liang L.
        • AI-Khatib S.M.
        • Curtis L.H.
        • LaBresh K.A.
        • Yancy C.W.
        • Albert N.M.
        • Peterson E.D.
        Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.
        JAMA. 2007; 298: 1525-1532